Effect of nucleos (t) ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis
T Kumada, H Toyoda, T Tada, S Kiriyama… - Journal of …, 2013 - Elsevier
BACKGROUND & AIMS: Some patients with chronic hepatitis B virus (HBV) infection
progress to hepatocellular carcinoma (HCC). However, the long-term effect of nucleos (t) ide
analogue (NA) therapy on progression to HCC is unclear. METHODS: Therefore, we
compared chronic hepatitis B patients who received NA therapy to those who did not, using
a propensity analysis. RESULTS: Of 785 consecutive HBV carriers between 1998 and 2008,
117 patients who received NA therapy and 117 patients who did not, were selected by …
progress to hepatocellular carcinoma (HCC). However, the long-term effect of nucleos (t) ide
analogue (NA) therapy on progression to HCC is unclear. METHODS: Therefore, we
compared chronic hepatitis B patients who received NA therapy to those who did not, using
a propensity analysis. RESULTS: Of 785 consecutive HBV carriers between 1998 and 2008,
117 patients who received NA therapy and 117 patients who did not, were selected by …
以上显示的是最相近的搜索结果。 查看全部搜索结果